1
|
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
|
Cancer Cell
|
2005
|
5.47
|
2
|
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.
|
Cancer Cell
|
2002
|
5.10
|
3
|
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors.
|
Clin Cancer Res
|
2008
|
4.02
|
4
|
Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America.
|
Am J Hum Genet
|
2003
|
2.88
|
5
|
Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.
|
N Engl J Med
|
2012
|
2.74
|
6
|
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor.
|
Cancer Discov
|
2013
|
2.11
|
7
|
Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis.
|
Fertil Steril
|
2003
|
2.00
|
8
|
PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
|
Cancer Res
|
2011
|
1.91
|
9
|
DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors.
|
J Clin Endocrinol Metab
|
2012
|
1.67
|
10
|
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.
|
Clin Cancer Res
|
2007
|
1.64
|
11
|
Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
|
Cancer
|
2008
|
1.54
|
12
|
Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.
|
Proc Natl Acad Sci U S A
|
2003
|
1.53
|
13
|
Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
|
Clin Cancer Res
|
2004
|
1.45
|
14
|
Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
|
PLoS Genet
|
2011
|
1.43
|
15
|
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.
|
Rev Sci Instrum
|
2009
|
1.42
|
16
|
Preoperative FLAC/granulocyte-colony-stimulating factor chemotherapy for stage II breast cancer: a prospective randomized trial.
|
Ann Surg Oncol
|
2003
|
1.39
|
17
|
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies.
|
Eur J Cancer
|
2009
|
1.36
|
18
|
Functional phosphodiesterase 11A mutations may modify the risk of familial and bilateral testicular germ cell tumors.
|
Cancer Res
|
2009
|
1.35
|
19
|
The spectrum of endometrial pathology induced by progesterone receptor modulators.
|
Mod Pathol
|
2008
|
1.33
|
20
|
Hereditary kidney cancer: unique opportunity for disease-based therapy.
|
Cancer
|
2009
|
1.32
|
21
|
Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants.
|
Cancer Res
|
2010
|
1.31
|
22
|
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
|
Cancer Res
|
2011
|
1.15
|
23
|
Multidrug-resistant Acinetobacter baumannii Harboring OXA-24 carbapenemase, Spain.
|
Emerg Infect Dis
|
2011
|
1.10
|
24
|
Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
|
Diagn Cytopathol
|
2008
|
1.08
|
25
|
Tissue-based research in kidney cancer: current challenges and future directions.
|
Clin Cancer Res
|
2008
|
1.07
|
26
|
Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas.
|
Cancer
|
2010
|
1.04
|
27
|
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
|
Cancer Immunol Immunother
|
2011
|
1.04
|
28
|
Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.
|
Cancer Res
|
2013
|
1.04
|
29
|
Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology.
|
J Vasc Interv Radiol
|
2012
|
1.02
|
30
|
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
|
Clin Cancer Res
|
2004
|
1.02
|
31
|
Ectopic adrenocorticotropic hormone and corticotropin-releasing hormone co-secreting tumors in children and adolescents causing cushing syndrome: a diagnostic dilemma and how to solve it.
|
J Clin Endocrinol Metab
|
2015
|
0.98
|
32
|
The role of 18F-FDG-PET in the local/regional evaluation of women with breast cancer.
|
Breast Cancer Res Treat
|
2002
|
0.97
|
33
|
Using location, color, size, and depth to characterize and identify endometriosis lesions in a cohort of 133 women.
|
Fertil Steril
|
2007
|
0.97
|
34
|
Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914.
|
Fertil Steril
|
2009
|
0.97
|
35
|
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
|
Cancer
|
2002
|
0.96
|
36
|
Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P.
|
Anticancer Res
|
2012
|
0.94
|
37
|
Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma/paraganglioma-polycythemia.
|
J Mol Med (Berl)
|
2014
|
0.93
|
38
|
Utilization of ancillary studies in thyroid fine needle aspirates: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference.
|
Diagn Cytopathol
|
2008
|
0.90
|
39
|
Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma.
|
Clin Cancer Res
|
2012
|
0.90
|
40
|
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.
|
J Urol
|
2007
|
0.90
|
41
|
A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report.
|
J Med Case Rep
|
2007
|
0.88
|
42
|
Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: report of a case and review of the literature.
|
Diagn Cytopathol
|
2006
|
0.88
|
43
|
Tyrosine hydroxylase, chromogranin A, and steroidogenic acute regulator as markers for successful separation of human adrenal medulla.
|
Cell Tissue Res
|
2010
|
0.83
|
44
|
Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl.
|
Endocr Relat Cancer
|
2010
|
0.82
|
45
|
Adenoid cystic/basal cell carcinoma of the prostate: review and update.
|
Arch Pathol Lab Med
|
2007
|
0.80
|
46
|
Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell.
|
Int J Cancer
|
2012
|
0.79
|
47
|
Differential genetic expression in large versus small clear cell renal cell carcinoma: results from microarray analysis.
|
J Cancer
|
2011
|
0.79
|
48
|
Reninoma presenting in pregnancy.
|
J Clin Endocrinol Metab
|
2014
|
0.77
|
49
|
Facial papules, spontaneous pneumothorax, and renal tumors.
|
J Am Acad Dermatol
|
2003
|
0.76
|
50
|
The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
|
J Urol
|
2011
|
0.76
|
51
|
Lipid cell tumors in two women with von Hippel-Lindau syndrome.
|
Obstet Gynecol
|
2010
|
0.75
|
52
|
MRI of angiolipoma of the breast in Turner's syndrome.
|
AJR Am J Roentgenol
|
2004
|
0.75
|